Shuttle Pharmaceuticals Provides Third Quarter 2023 Corporate Update
ROCKVILLE, Md., Nov. 14, 2023 /PRNewswire/ — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), today provided a corporate update in connection with the filing of its Quarterly Report on Form 10-Q for the quarter ended September 30, 2023.
Related news for (SHPH)
- Today’s Top Performers: MoBot’s Market Review 07/15/25 05:00 PM
- MoBot’s Stock Market Highlights – 07/15/25 04:00 PM
- Today’s Top Performers: MoBot’s Market Review 05/12/25 05:00 AM
- MoBot alert highlights: NASDAQ: NXTT, NASDAQ: SHPH, NASDAQ: BTCS, NASDAQ: TAOP, NASDAQ: JYD (05/12/25 04:00 AM)
- Today’s Sizzling Stocks to Trade – SYTA, WBUY, SHPH, SRXH, NVVE, and ZKIN Deliver Explosive News-Driven Moves